Hes1: a key role in stemness, metastasis and multidrug resistance
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Hes1 is one mammalian counterpart of the Hairy and Enhancer of split proteins that play a critical role in many physiological processes including cellular differentiation, cell cycle arrest, apoptosis and self-renewal ability. Recent studies have shown that Hes1 functions in the maintenance of cancer stem cells (CSCs), metastasis and antagonizing drug-induced apoptosis. Pathways that are involved in the up-regulation of Hes1 level canonically or non-canonically, such as the Hedgehog, Wnt and hypoxia pathways are frequently aberrant in cancer cells. Here, we summarize the recent data supporting the idea that Hes1 may have an important function in the maintenance of cancer stem cells self-renewal, cancer metastasis, and epithelial-mesenchymal transition (EMT) process induction, as well as chemotherapy resistance, and conclude with the possible mechanisms by which Hes1 functions have their effect, as well as their crosstalk with other carcinogenic signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · cited 1×
“capacity and quiescence.(53,54) This may provide a new avenue to target CSCs, as the Hes1 anti-drug effect has been recently discovered.”
BackgroundHypoxia requires Notch signaling to maintain the undifferentiated cell state
Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J. L., Poellinger, L., Lendahl, U., & Bondesson, M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.010 · Cited by 1,109
Hes1 and Hes5 as Notch effectors in mammalian neuronal differentiation
Ohtsuka, T., Ishibashi, M., Gradwohl, G., Nakanishi, S., Guillemot, F., & Kageyama, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2196 · Cited by 852
Hilton, M. J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., Kronenberg, H. M., Teitelbaum, S. L., Ross, F. P., Kopan, R., et al. (2008) · Nature Medicine · doi:10.1038/nm1716 · Cited by 604
Mourikis, P., Sambasivan, R., Castel, D., Rocheteau, P., Bizzarro, V., & Tajbakhsh, S. (2012) · Stem Cells · doi:10.1002/stem.775 · Cited by 526
Chen, J., Imanaka, N., Chen, J., & Griffin, J. D. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605486 · Cited by 346 · cited 1×
“Hes1 may promote tumor cell growth and the self-renewal phenotype under hypoxia conditions or Notch stimulation.(30,31) Downstream factors of Hes1, which tend to be differentiating makers, such as Mash1 and NeuroD show dose- and time-dependent response to Hes1 inhibition treatment in cancer progression, confirming the…”
BackgroundControl of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1
Sang, L., Coller, H. A., & Roberts, J. M. (2008) · Science · doi:10.1126/science.1155998 · Cited by 313 · cited 2×
“However, sustained activation of Notch-p21 contributes to an irreversible senescent phenotype.(8,66) In contrast, cells that express full-length Hes1 genes resume proliferation, after a p21-induced senescent phenotype, as Hes1 transcriptionally represses p21 in a bHLH domain-dependent manner and Hes1 keeps quiescent c…”
BackgroundQiang, L., Wu, T., Zhang, H.-W., Lu, N., Hu, R., Wang, Y.-J., Zhao, L., Chen, F.-H., Wang, X.-T., You, Q.-D., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.95 · Cited by 313
Lee, S. H., Hong, H. S., Liu, Z. X., Kim, R. H., Kang, M. K., Park, N.-H., & Shin, K.-H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.065 · Cited by 120
Self-citation
Cited by
Zhu, S., Chen, W., Masson, A., & Li, Y.-P. (2024) · Cell Discovery · doi:10.1038/s41421-024-00689-6 · Cited by 463
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Wang, J., Zhu, M., Zhu, J., Li, J., Zhu, X., Wang, K., Shen, K., Yang, K., Ni, X., Liu, X., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01707-4 · Cited by 41
Nasser, F., Moussa, N., Helmy, M. W., & Haroun, M. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01988-x · Cited by 29
Metadata
- Authors
- Liu, Z.-H., Dai, X.-M., & Du, B.
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2015-03-04
- Volume
- 16
- Issue
- 3
- Pages
- 353-359
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- OpenAlex
- W1904460196
- Cited by
- 201
- References
- 9
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hes1: a key role in stemness, metastasis and multidrug resistance. https://app.cochat.ai/papers/10.1080/15384047.2015.1016662
- The paper
- Liu, Z.-H., Dai, X.-M., & Du, B. (2015). Hes1: a key role in stemness, metastasis and multidrug resistance. Cancer Biology & Therapy. https://doi.org/10.1080/15384047.2015.1016662
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.